{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:29:34Z","timestamp":1794490174782,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA20140"],"award-info":[{"award-number":["CA20140"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["429280966"],"award-info":[{"award-number":["429280966"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB TRR 305"],"award-info":[{"award-number":["SFB TRR 305"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xpro.2026.104568","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:28:18Z","timestamp":1779182898000},"page":"104568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protocol for validating drug efficacy and safety in scalable 96-well platforms of human cortical organoids and melanoma brain metastases"],"prefix":"10.1016","volume":"7","author":[{"given":"Kim","family":"Krieg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima-Zahra","family":"Rachad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Wittich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Kauven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-316X","authenticated-orcid":false,"given":"Ole","family":"Pless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2026.104568_bib1","article-title":"Cortical organoid-derived models of the melanoma brain metastatic niche enable prioritization of cancer-targeting drugs","volume":"5","author":"Krieg","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xpro.2026.104568_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-020-00300-6","article-title":"Cancer progression and the invisible phase of metastatic colonization","volume":"20","author":"Klein","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xpro.2026.104568_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","article-title":"Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases","volume":"153","author":"Luzzi","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xpro.2026.104568_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104568_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.trecan.2018.01.003","article-title":"The Evolving Landscape of Brain Metastasis","volume":"4","author":"Valiente","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xpro.2026.104568_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xpro.2026.104568_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-020-03419-6","article-title":"Mapping distribution of brain metastases: does the primary tumor matter?","volume":"147","author":"Schroeder","year":"2020","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xpro.2026.104568_bib8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xpro.2026.104568_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xpro.2026.104568_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xpro.2026.104568_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xpro.2026.104568_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-017-02674-y","article-title":"Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma","volume":"9","author":"Werner-Klein","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104568_bib13","article-title":"Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscape","volume":"51","author":"Czogalla","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.xpro.2026.104568_bib14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/cncr.32714","article-title":"Current multidisciplinary management of brain metastases","volume":"126","author":"Moravan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.xpro.2026.104568_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xpro.2026.104568_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104568_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Pa\u015fca","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xpro.2026.104568_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.stem.2025.01.002","article-title":"Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy","volume":"32","author":"Peng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104568_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881989","article-title":"Organoids as a Systems Platform for SCLC Brain Metastasis","volume":"12","author":"Quaranta","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xpro.2026.104568_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13058-024-01865-y","article-title":"Utilizing human cerebral organoids to model breast cancer brain metastasis in culture","volume":"26","author":"Wang","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xpro.2026.104568_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2016.12.013","article-title":"Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders","volume":"20","author":"Lorenz","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104568_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.scr.2018.10.004","article-title":"Generation of two human isogenic iPSC lines from fetal dermal fibroblasts","volume":"33","author":"Tandon","year":"2018","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xpro.2026.104568_bib23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104568_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s43018-025-00963-w","article-title":"MCSP(+) metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization","volume":"6","author":"Guetter","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xpro.2026.104568_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s44321-025-00339-8","article-title":"Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients","volume":"18","author":"Weidele","year":"2026","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xpro.2026.104568_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xpro.2026.104568_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature22330","article-title":"Assembly of functionally integrated human forebrain spheroids","volume":"545","author":"Birey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104568_bib28","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.stemcr.2023.08.003","article-title":"ISSCR standards for the use of human stem cells in basic research","volume":"18","author":"Ludwig","year":"2023","journal-title":"Stem Cell Rep."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:51:11Z","timestamp":1794487871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166726002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666166726002212"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104568","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for validating drug efficacy and safety in scalable 96-well platforms of human cortical organoids and melanoma brain metastases","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2025.101236","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104568"}}